Edison Pharmaceuticals' Series E Round

Edison Pharmaceuticals raised a round of funding on September 14, 2011.

Edison Pharmaceuticals is developing treatments for inherited mitochondrial disease - a genetic disorder that share as a common link defects in how cells make and regulate energy. The company has buil…

Articles about Edison Pharmaceuticals' Series E Round: